Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 3270 entries
View as:

Cohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT01499914 Org: User:
Start: 11/30/09 End: 12/31/12 Due: 12/31/13

Cryopreservation of Ovarian Cortex in Girls With Turner Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01410045 Org: User:
Start: 01/31/11 End: 02/28/31 Due: 02/28/32

Efficiency of Comprehensive Chromosomal Testing of Trophectoderm Biopsies of Blastocysts in In Vitro Fertilization

Phase: N/A Priority: Normal
NCT ID: NCT04758819 Org: User:
Start: 07/12/21 End: 01/31/26 Due: 01/31/27

Prediction of Chronic Renal Disease After Acute Kidney Injury in the Intensive Care Unit

Phase: N/A Priority: Normal
NCT ID: NCT03282409 Org: User:
Start: 04/26/18 End: 05/31/25 Due: 05/31/26

Early Mobilisation and Relational Touch Practice on Intubated Patients of Intensive Care Unit

Phase: N/A Priority: Normal
NCT ID: NCT05903378 Org: User:
Start: 12/31/25 End: 06/30/26 Due: 06/30/27

Parenting and CAH - 21-hydroxylase Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT06900153 Org: User:
Start: 06/30/25 End: 06/30/26 Due: 06/30/27

Clopidogrel and Response Variability Investigation Study 2

Phase: N/A Priority: Normal
NCT ID: NCT00822666 Org: User:
Start: 10/31/08 End: 12/31/09 Due: 12/31/10

Neoadjuvant and Adjuvant Lenvatinib in HCC Patients Treated by Percutaneous Ablative

Phase: N/A Priority: Normal
NCT ID: NCT05113186 Org: User:
Start: 02/02/22 End: 10/02/26 Due: 10/02/27

BARIcitinib Cognitive Emotional and Neural signaTuRE

Phase: N/A Priority: Normal
NCT ID: NCT05238896 Org: User:
Start: 06/27/22 End: 03/31/23 Due: 03/31/24

Impact of Global Care of the Pain at Chronic Painful Patients Affected by Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT01915875 Org: User:
Start: 02/15/12 End: 11/19/14 Due: 11/19/15

Blood Collection to Validated New Therapeutics Strategies Against Preeclampsia

Phase: N/A Priority: Normal
NCT ID: NCT03188900 Org: User:
Start: 06/12/17 End: 06/12/19 Due: 06/12/20

Prevention of C.Difficile Infections With Oral Vancomycine in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT05256693 Org: User:
Start: 03/31/22 End: 07/31/25 Due: 07/31/26

Levels of Contaminants in Human Milk

Phase: N/A Priority: Normal
NCT ID: NCT01848444 Org: User:
Start: 10/31/13 End: 05/31/15 Due: 05/31/16

Evolution of Lymphocyte Populations Under Biotherapy in Inflammatory Bowel Disease

Phase: N/A Priority: Normal
NCT ID: NCT02693340 Org: User:
Start: 02/29/16 End: 03/31/20 Due: 03/31/21

Nasality Evolution in a Nasal Polyposis Context : Multiparametric Evaluation : Articulatory (Imaging), Aerodynamics, Acoustics and Perception

Phase: N/A Priority: Normal
NCT ID: NCT05131958 Org: User:
Start: 12/31/21 End: 12/31/22 Due: 12/31/23

Diagnosis of Congenital CMV Infection in Neonates Who Failed Newborn Hearing Screening

Phase: N/A Priority: Normal
NCT ID: NCT02139423 Org: User:
Start: 11/22/14 End: 10/19/20 Due: 10/19/21

MoMa Signature During Granulomatosis

Phase: N/A Priority: Normal
NCT ID: NCT05916638 Org: User:
Start: 01/15/24 End: 10/31/25 Due: 10/31/26

Evaluation of NETs in Patients With Solid Cancers Associated With a High Risk of Venous Thromboembolic Events

Phase: N/A Priority: Normal
NCT ID: NCT04294589 Org: User:
Start: 07/01/19 End: 12/31/20 Due: 12/31/21

Involvement of the Immune System in Intrinsic Radiosensitivity

Phase: N/A Priority: Normal
NCT ID: NCT06826066 Org: User:
Start: 04/10/25 End: 02/10/27 Due: 02/10/28

Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation

Phase: N/A Priority: Normal
NCT ID: NCT02231229 Org: User:
Start: 07/23/14 End: 02/18/20 Due: 02/18/21

Sentinel Node and Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00987051 Org: User:
Start: 04/30/07 End: 10/31/11 Due: 10/31/12

Personalized and Automated Digital Coaching in People With Non-specific Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT06498271 Org: User:
Start: 09/30/24 End: 03/31/26 Due: 03/31/27

Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by Electroporation

Phase: N/A Priority: Normal
NCT ID: NCT03630640 Org: User:
Start: 10/11/18 End: 08/19/23 Due: 08/19/24

Craniopharyngioma and Pregnancies

Phase: N/A Priority: Normal
NCT ID: NCT06801756 Org: User:
Start: 03/24/25 End: 03/24/26 Due: 03/24/27

Study of One Protein Implicated in Wegener Disease

Phase: N/A Priority: Normal
NCT ID: NCT01167491 Org: User:
Start: 05/31/10 End: 09/30/14 Due: 09/30/15